On the Perreault schema of relators and rules of formation in UDC : papers /

por Perreault, Jean M., Wesseling, J. C. G.
Publicado 1966.

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

por Wesseling, J, van der Valk, S W, Hilkens, J
Publicado 1996

Nucleus-associated phosphorylation of Ins(1,4,5)P3 to InsP6 in Dictyostelium.

por Van der Kaay, J, Wesseling, J, Van Haastert, P J
Publicado 1995

Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.

por Kwa, H. B., Wesseling, J., Verhoeven, A. H., van Zandwijk, N., Hilkens, J.
Publicado 1996

Diminished milk fat secretion and premature mammary gland involution in episialin/MUC1 transgenic mice

por Wesseling, J, Maas, A, Hageman, P, Storm, J, van der Valk, M, Hilkens, J
Publicado 2001

Genomic organization and expression of the 3′ end of the canine and feline enteric coronaviruses

por Vennema, H., Rossen, J.W.A., Wesseling, J., Horzinek, M.C., Rottier, P.J.M.
Publicado en Virology (1992)

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

por Knauer, M, Cardoso, F, Wesseling, J, Bedard, P L, Linn, S C, Rutgers, E J T, van 't Veer, L J
Publicado 2010

Increased risk of colorectal neoplasia in asymptomatic liver‐transplant recipients

por Koornstra, J J, Wesseling, J, de Jong, A E, Vasen, H F A, Kleibeuker, J H, Haagsma, E B
Publicado 2007

Differential expression and distribution of epithelial adhesion molecules in non‐small cell lung cancer and normal bronchus

por Boelens, M C, van den Berg, A, Vogelzang, I, Wesseling, J, Postma, D S, Timens, W, Groen, H J M
Publicado 2007

Independent Induction of Caspase-8 and cFLIP Expression during Colorectal Carcinogenesis in Sporadic and HNPCC Adenomas and Carcinomas

por Heijink, D. M., Kleibeuker, J. H., Jalving, M., Boersma-van Ekb, W., Koornstra, J. J., Wesseling, J., de Jong, S.
Publicado en Cell Oncol (2007)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response

por Lips, E. H., Mulder, L., de Ronde , J. J., Mandjes, I. A. M., Koolen, B. B., Wessels, L. F. A., Rodenhuis, S., Wesseling, J.
Publicado 2013

Source apportionment to support air quality planning: Strengths and weaknesses of existing approaches

por Thunis, P., Clappier, A., Tarrason, L., Cuvelier, C., Monteiro, A., Pisoni, E., Wesseling, J., Belis, C.A., Pirovano, G., Janssen, S., Guerreiro, C., Peduzzi, E.
Publicado en Environ Int (2019)

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers

por Lips, E H, Mulder, L, Oonk, A, van der Kolk, L E, Hogervorst, F B L, Imholz, A L T, Wesseling, J, Rodenhuis, S, Nederlof, P M
Publicado 2013

Enrichment of high-grade tumors in breast cancer gene expression studies

por van Seijen, M., Mooyaart, A. L., Mulder, L., Hoogstraat, M., Drukker, C. A., Loo, C. E., Pouw, B., Sonke, G. S., Wesseling, J., Lips, E. H.
Publicado en Breast Cancer Res Treat (2017)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

por Straver, M. E., Rutgers, E. J. Th., Rodenhuis, S., Linn, S. C., Loo, C. E., Wesseling, J., Russell, N. S., Oldenburg, H. S. A., Antonini, N., Vrancken Peeters, M. T. F. D.
Publicado 2010

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening

por van Luijt, P. A., Heijnsdijk, E. A. M., Fracheboud, J., Overbeek, L. I. H., Broeders, M. J. M., Wesseling, J., den Heeten, G. J., de Koning, H. J.
Publicado en Breast Cancer Res (2016)

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

por Drukker, CA, Bueno-de-Mesquita, JM, Retèl, VP, van Harten, WH, van Tinteren, H, Wesseling, J, Roumen, RMH, Knauer, M, van 't Veer, LJ, Sonke, GS, Rutgers, EJT, van de Vijver, MJ, Linn, SC
Publicado 2013

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

por Rigter, L S, Loo, C E, Linn, S C, Sonke, G S, van Werkhoven, E, Lips, E H, Warnars, H A, Doll, P K, Bruining, A, Mandjes, I A, Vrancken Peeters, M J, Wesseling, J, Gilhuijs, K G, Rodenhuis, S
Publicado 2013

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

por van Roozendaal, L. M., Goorts, B., Klinkert, M., Keymeulen, K. B. M. I., De Vries, B., Strobbe, L. J. A., Wauters, C. A. P., van Riet, Y. E., Degreef, E., Rutgers, E. J. T., Wesseling, J., Smidt, M. L.
Publicado en Breast Cancer Res Treat (2016)

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

por Leegte, B, van der Hout, A H, Deffenbaugh, A, Bakker, M, Mulder, I, ten, B, Leenders, E, Wesseling, J, de Hullu, J, Hoogerbrugge, N, Ligtenberg, M, Ardern-Jones, A, Bancroft, E, Salmon, A, Barwell, J, Eeles, R, Oosterwijk, J
Publicado 2005